2026 MedTech M&A Surge, Nona's Immunology Push, Stellaromics' Brain Research, and AI in Biotech cover art

2026 MedTech M&A Surge, Nona's Immunology Push, Stellaromics' Brain Research, and AI in Biotech

2026 MedTech M&A Surge, Nona's Immunology Push, Stellaromics' Brain Research, and AI in Biotech

Listen for free

View show details

About this listen

 In this episode, we explore the dynamic landscape of the medical device industry as it heads into 2026, with mergers and acquisitions taking center stage. We discuss Boston Scientific's significant acquisition of Penumbra and the challenges posed by expiring Affordable Care Act subsidies and tariffs. We also delve into the ongoing negotiations for the Medical Device User Fee Amendments and the competitive field of surgical robotics. Next, we highlight Nona Biosciences' co-founding of the Innovative Alliance for Translational Medicine in Immunological Diseases, aiming to advance research and clinical trials in immunological diseases. We then turn to Stellaromics' expansion of its Pyxa™ 3D spatial transcriptomics program, now installed at Emory University, to enhance research into RNA regulation in neurodegenerative diseases. Meanwhile, a collaboration in Taiwan has developed an exosome-based drug delivery platform for Parkinson's disease, showing promise in preclinical studies. In other news, the U.S. Department of Health and Human Services has issued new guidance to reduce prescription drug prices through Direct-to-Consumer programs, aiming to make medications more affordable. We also discuss the biotech industry's challenge with AI-driven medical breakthroughs, emphasizing the need for accessible AI infrastructure to ensure diverse innovation. Finally, BioMed X partners with Barbados and the EU to launch a project improving AI-based early diabetic kidney disease modeling, focusing on the Barbadian population's health challenges. Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.medtechdive.com/news/medtech-trends-outlook-2026/810902/https://www.biospace.com/press-releases/nona-biosciences-co-founds-innovative-alliance-for-translational-medicine-in-immunological-diseases-advancing-a-new-iit-driven-ecosystemhttps://www.biospace.com/press-releases/stellaromics-expands-pyxa-3d-spatial-transcriptomics-beta-program-with-installation-at-emory-university-school-of-medicinehttps://www.biospace.com/press-releases/cmuh-ever-supreme-team-develops-world-first-brain-targeting-exosome-delivering-curcumin-across-the-blood-brain-barrier-for-parkinsons-diseasehttps://www.pharmexec.com/view/daily-disconnect-between-pharma-medtechhttps://pharmaphorum.com/digital/ais-promise-biotechs-peril-how-unequal-access-computing-power-threatens-medicalhttps://www.genengnews.com/topics/translational-medicine/barbados-government-and-biomed-x-partner-to-improve-ai-based-early-diabetic-kidney-disease-modeling
No reviews yet